Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

208 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Recombinant zoster vaccine and the risk of dementia.
Tang E, Ray I, Arnold BF, Acharya NR. Tang E, et al. Among authors: acharya nr. Vaccine. 2024 Dec 28;46:126673. doi: 10.1016/j.vaccine.2024.126673. Online ahead of print. Vaccine. 2024. PMID: 39733478
Visual recovery in treated bacterial keratitis.
Srinivasan M, Mascarenhas J, Rajaraman R, Ravindran M, Lalitha P, Ray KJ, Zegans ME, Acharya NR, Lietman TM, Keenan JD; Steroids for Corneal Ulcers Trial Group. Srinivasan M, et al. Among authors: acharya nr. Ophthalmology. 2014 Jun;121(6):1310-1. doi: 10.1016/j.ophtha.2013.12.041. Epub 2014 Mar 5. Ophthalmology. 2014. PMID: 24612976 Free PMC article. Clinical Trial.
Macular Edema Ranibizumab v. Intravitreal anti-inflammatory Therapy (MERIT) Trial-24-week Outcomes of Uveitic Macular Edema Retreatment.
Multicenter Uveitis Steroid Treatment Trial (MUST) Research Group, Writing Committee; Gonzales J, Acharya NR, Sugar EA, Burke AE, Vitale AT, Gupta V, Dunn JP, Lightman SL, Thorne JE, Kim RY, Yeh S, Altaweel MM, Kempen JH, Holbrook JT, Jabs DA. Multicenter Uveitis Steroid Treatment Trial (MUST) Research Group, Writing Committee, et al. Among authors: acharya nr. Ophthalmology. 2024 Nov 27:S0161-6420(24)00746-2. doi: 10.1016/j.ophtha.2024.11.021. Online ahead of print. Ophthalmology. 2024. PMID: 39612949
Navigating the Realm of Claims-Based Research.
Sun CQ, Acharya NR. Sun CQ, et al. Among authors: acharya nr. Ophthalmology. 2024 Oct;131(10):1139-1142. doi: 10.1016/j.ophtha.2024.05.016. Ophthalmology. 2024. PMID: 39306362 No abstract available.
Association Between Baseline Macular Morphologic Features on Optical Coherence Tomography and Visual Outcomes in Patients with Vogt-Koyanagi-Harada Disease.
Sundararajan M, Rathinam SR, Thundikandy R, Kanakath A, Balamurugan S, Vedhanayaki R, Miller DC, Lim LL, Suhler EB, Al-Dhibi HA, Arellanes-Garcia L, Reddy AK, Feng S, Doan T, Porco TC, Shantha JG, Acharya NR, Gonzales JA. Sundararajan M, et al. Among authors: acharya nr. Ocul Immunol Inflamm. 2024 Aug 27:1-8. doi: 10.1080/09273948.2024.2391420. Online ahead of print. Ocul Immunol Inflamm. 2024. PMID: 39190826
Outcomes in Patients With Vogt-Koyanagi-Harada Disease From the First-Line Antimetabolites for Steroid-Sparing Treatment Uveitis Trial.
Acharya NR, Rathinam SR, Thundikandy R, Kanakath A, Murugan SB, Vedhanayaki R, Gonzales JA, Lim LL, Suhler EB, Al-Dhibi HA, Doan T, Arellanes-Garcia L, Coyne A, Porco TC, Shantha JG; FAST Research Group. Acharya NR, et al. Am J Ophthalmol. 2024 Nov;267:100-111. doi: 10.1016/j.ajo.2024.06.004. Epub 2024 Jun 22. Am J Ophthalmol. 2024. PMID: 38909740 Clinical Trial.
208 results